Semprus BioSciences Secures $8,000,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24c711d8-4ae0-4fff-a92d-af6606c063e9&Preview=1 -
Date
12/14/2008 -
Company Name
Semprus BioSciences -
Mailing Address
One Kendall Street Building 1400, 1st Floor Cambridge, MA 02139 -
Company Description
Semprus BioSciences is a venture-backed biotechnology company developing functional surfaces to prevent medical device complications. Our initial product development efforts are focused on the first implantable and permanently antimicrobial surface technology. The intellectual property comes from the MIT labs of Prof. Robert Langer and Prof. Greg Stephanopoulos, and part of this scientific research was featured in Nature. -
Website
http://www.semprusbio.com -
Transaction Type
Venture Equity -
Transaction Amount
$8,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The proceeds of this financing will be used to advance SEMPRUS’ product candidates. -
M&A Terms
-
Venture Investor
5AM Ventures -
Venture Investor
Pangaea Ventures
